Holen Sie sich die Stockscreener-App
244.99
0.39%
-1.21
Handel nachbörslich:
245.00
0.010
+0.00%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt STE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$246.20
Offen:
$245.63
24-Stunden-Volumen:
426.56K
Relative Volume:
0.67
Marktkapitalisierung:
$24.07B
Einnahmen:
$5.12B
Nettoeinkommen (Verlust:
$434.80M
KGV:
55.93
EPS:
4.38
Netto-Cashflow:
$680.11M
1W Leistung:
-0.44%
1M Leistung:
+8.87%
6M Leistung:
+12.77%
1J Leistung:
+9.78%
1-Tages-Spanne:
$244.01
$246.64
1-Wochen-Bereich:
$242.10
$247.24
52-Wochen-Spanne:
$200.98
$252.79
Steris Plc Stock (STE) Company Profile
Firmenname
Steris Plc
Sektor
Branche
Telefon
35312322000
Adresse
70 SIR JOHN ROGERSON'S QUAY, DUBLIN
Vergleichen Sie STE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STE
Steris Plc
|
244.99 | 24.61B | 5.12B | 434.80M | 680.11M | 4.38 |
|
ABT
Abbott Laboratories
|
132.04 | 235.23B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.53 | 157.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.38 | 148.87B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
81.26 | 110.72B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.65 | 45.66B | 5.54B | 4.18B | 623.10M | 7.00 |
Steris Plc Stock (STE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-24 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2023-05-30 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-04-14 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-23 | Herabstufung | Needham | Buy → Hold |
| 2022-07-14 | Eingeleitet | Piper Sandler | Overweight |
| 2022-04-07 | Eingeleitet | Wolfe Research | Outperform |
| 2021-05-26 | Hochstufung | Needham | Hold → Buy |
| 2021-02-04 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-06-09 | Eingeleitet | Needham | Hold |
| 2019-07-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2018-01-03 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-06-05 | Herabstufung | Wellington Shields | Gradually Accumulate → Hold |
| 2017-05-03 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2016-11-30 | Eingeleitet | Goldman | Neutral |
| 2016-06-03 | Hochstufung | Northcoast | Neutral → Buy |
| 2015-06-12 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2013-05-07 | Herabstufung | Griffin Securities | Buy → Hold |
| 2013-02-08 | Bestätigt | Griffin Securities | Buy |
| 2012-08-03 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2012-02-08 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2011-11-03 | Bestätigt | JMP Securities | Mkt Outperform |
| 2011-02-09 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-12-21 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-09-17 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2010-04-07 | Bestätigt | CL King | Strong Buy |
| 2010-03-26 | Eingeleitet | CL King | Strong Buy |
| 2010-03-03 | Eingeleitet | Brean Murray | Hold |
Alle ansehen
Steris Plc Aktie (STE) Neueste Nachrichten
Sterilization Monitoring Market Surges Towards USD 1.31 Billion by 2030 Amid Rising Demand for Real-Time Validation - GlobeNewswire Inc.
August 15th Options Now Available For STERIS - Nasdaq
STERIS Stock: Is Wall Street Bullish or Bearish? - MSN
STERIS Stock: Is Wall Street Bullish Or Bearish? - Barchart.com
Is it the Right Time to Hold STERIS Stock in Your Portfolio? - MSN
STERIS’s SWOT analysis: infection prevention leader’s stock faces challenges By Investing.com - Investing.com India
STERIS’s SWOT analysis: infection prevention leader’s stock faces challenges - Investing.com
STERIS plc (NYSE:STE) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
AST Business Growth & Strategic Acquisitions Support STERIS Stock - MSN
Cetera Investment Advisers Has $1.43 Million Holdings in STERIS plc (NYSE:STE) - Defense World
Are Options Traders Betting on a Big Move in STERIS (STE) Stock? - Yahoo Finance
Why Steris PLC (STE) Is Set to Outperform the Market: Insights i - GuruFocus
Steris Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
Steris (STE) Target Price Raised by Morgan Stanley | STE Stock N - GuruFocus
Why Steris PLC (STE) Is Set to Outperform the Market: Insights into Financial Growth and Competitive Advantage - GuruFocus
Deciphering Steris (STE) International Revenue Trends - Yahoo Finance
Stephens Adjusts STERIS Price Target to $280 From $250, Maintains Overweight Rating - marketscreener.com
Steris outlines 6% to 7% revenue growth and $9.90–$10.15 EPS for fiscal 2026 amid tariff headwinds - MSN
STERIS stock target raised to $280 at Citizens JMP By Investing.com - Investing.com South Africa
Steris (STE) Price Target Raised by JMP Securities | STE Stock News - GuruFocus
Morgan Stanley Adjusts STERIS Price Target to $260 From $240 - marketscreener.com
STERIS plc (NYSE:STE) Q4 2025 Earnings Call Transcript - Insider Monkey
Steris (STE) Price Target Boosted to $280 by Citizens JMP | STE Stock News - GuruFocus
Piper Sandler Adjusts Price Target on STERIS to $280 From $265, Maintains Overweight Rating - marketscreener.com
STERIS stock target raised to $280 at Citizens JMP - Investing.com
STERIS Reports Strong Fiscal 2025 Results and Positive Outlook - TipRanks
Steris PLC (STE) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook - Yahoo Finance
STERIS plc (Ireland) (STE) Stock Forecasts - Yahoo Finance
Steris Reports Strong Earnings Amid Challenges - TipRanks
STERIS Q4 2025 Earnings Call Transcript - MarketBeat
Steris: May Benefit From Bringing Pharmaceutical Manufacturing Back To The U.S. (NYSE:STE) - Seeking Alpha
U.S. Markets Closed Mixed Thursday As Steris Led, Fiserv Lagged - Barron's
Earnings call transcript: STERIS Beats Q4 2025 EPS Forecast, Stock Rises 5.9% - Investing.com Nigeria
STERIS (STE) Surpasses Q4 Revenue Expectations, Reports Record Year | STE Stock News - GuruFocus
Steris (STE) Retains Overweight Rating with Price Target of $250 - GuruFocus
Transcript : STERIS plc, Q4 2025 Earnings Call, May 15, 2025 - marketscreener.com
Steris (STE) Retains Overweight Rating with Price Target of $250 | STE Stock News - GuruFocus
STE Q4 Earnings Beat, Margins Expand, Stock Up in Aftermarket - TradingView
Steris PLC Surpasses Q4 Estimates with $2.74 EPS and $1.5 Billio - GuruFocus
STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year - The Manila Times
Here's What Key Metrics Tell Us About Steris (STE) Q4 Earnings - Yahoo Finance
Steris (STE) Surpasses Q4 Earnings Estimates - Yahoo Finance
STERIS (STE) Surpasses Q4 Revenue Expectations, Reports Record Y - GuruFocus
STERIS Announces Financial Results for Fiscal 2025 Fourth Quarte - GuruFocus
Steris forecasts annual profit above estimates on strong medical equipment sales - marketscreener.com
STERIS plc reports results for the quarter ended March 31Earnings Summary - TradingView
STERIS Announces Financial Results For Fiscal 2025 Fourth Quarter And Full Year - marketscreener.com
STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year | STE Stock News - GuruFocus
STERIS plc Reports 6% Revenue Growth and Increased EPS for Fiscal Year 2025; Provides Fiscal 2026 Outlook - Nasdaq
Cisco, STERIS, and Dynatrace set to report earnings Wednesday - Investing.com
Sterilization Services Market Is Booming Worldwide 2025-2032 | - openPR.com
Finanzdaten der Steris Plc-Aktie (STE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.00%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):